These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Tumor acidity activated triphenylphosphonium-based mitochondrial targeting nanocarriers for overcoming drug resistance of cancer therapy. Yu H; Li JM; Deng K; Zhou W; Wang CX; Wang Q; Li KH; Zhao HY; Huang SW Theranostics; 2019; 9(23):7033-7050. PubMed ID: 31660085 [TBL] [Abstract][Full Text] [Related]
25. The antitumor effect of a new docetaxel-loaded microbubble combined with low-frequency ultrasound in vitro: preparation and parameter analysis. Ren ST; Liao YR; Kang XN; Li YP; Zhang H; Ai H; Sun Q; Jing J; Zhao XH; Tan LF; Shen XL; Wang B Pharm Res; 2013 Jun; 30(6):1574-85. PubMed ID: 23417512 [TBL] [Abstract][Full Text] [Related]
26. Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. Rapoport N; Gao Z; Kennedy A J Natl Cancer Inst; 2007 Jul; 99(14):1095-106. PubMed ID: 17623798 [TBL] [Abstract][Full Text] [Related]
27. Development of novel self-assembled ES-PLGA hybrid nanoparticles for improving oral absorption of doxorubicin hydrochloride by P-gp inhibition: In vitro and in vivo evaluation. Wang J; Li L; Wu L; Sun B; Du Y; Sun J; Wang Y; Fu Q; Zhang P; He Z Eur J Pharm Sci; 2017 Mar; 99():185-192. PubMed ID: 27989702 [TBL] [Abstract][Full Text] [Related]
28. Primary M1 macrophages as multifunctional carrier combined with PLGA nanoparticle delivering anticancer drug for efficient glioma therapy. Pang L; Zhu Y; Qin J; Zhao W; Wang J Drug Deliv; 2018 Nov; 25(1):1922-1931. PubMed ID: 30465444 [TBL] [Abstract][Full Text] [Related]
29. Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy. Tahir N; Madni A; Correia A; Rehman M; Balasubramanian V; Khan MM; Santos HA Int J Nanomedicine; 2019; 14():4961-4974. PubMed ID: 31308666 [No Abstract] [Full Text] [Related]
30. Ultrasound/microbubble-mediated targeted delivery of anticancer microRNA-loaded nanoparticles to deep tissues in pigs. Di Ianni T; Bose RJC; Sukumar UK; Bachawal S; Wang H; Telichko A; Herickhoff C; Robinson E; Baker S; Vilches-Moure JG; Felt SA; Gambhir SS; Paulmurugan R; Dahl JD J Control Release; 2019 Sep; 309():1-10. PubMed ID: 31326463 [TBL] [Abstract][Full Text] [Related]
31. Luminescent/magnetic PLGA-based hybrid nanocomposites: a smart nanocarrier system for targeted codelivery and dual-modality imaging in cancer theranostics. Shen X; Li T; Chen Z; Geng Y; Xie X; Li S; Yang H; Wu C; Liu Y Int J Nanomedicine; 2017; 12():4299-4322. PubMed ID: 28652734 [TBL] [Abstract][Full Text] [Related]
32. Doxorubicin liposome-loaded microbubbles for contrast imaging and ultrasound-triggered drug delivery. Escoffre JM; Mannaris C; Geers B; Novell A; Lentacker I; Averkiou M; Bouakaz A IEEE Trans Ultrason Ferroelectr Freq Control; 2013 Jan; 60(1):78-87. PubMed ID: 23287915 [TBL] [Abstract][Full Text] [Related]
33. Bypassing multidrug resistant ovarian cancer using ultrasound responsive doxorubicin/curcumin co-deliver alginate nanodroplets. Baghbani F; Moztarzadeh F Colloids Surf B Biointerfaces; 2017 May; 153():132-140. PubMed ID: 28235723 [TBL] [Abstract][Full Text] [Related]
34. The relationship between surface drug distribution of Dox-loaded microbubbles and drug release/cavitation behaviors with ultrasound. Lin CW; Fan CH; Yeh CK Ultrason Sonochem; 2024 Jan; 102():106728. PubMed ID: 38103369 [TBL] [Abstract][Full Text] [Related]
35. PEGylated-PLGA Nanoparticles Coated with pH-Responsive Tannic Acid-Fe(III) Complexes for Reduced Premature Doxorubicin Release and Enhanced Targeting in Breast Cancer. Hu F; Zhang R; Guo W; Yan T; He X; Hu F; Ren F; Ma X; Lei J; Zheng W Mol Pharm; 2021 Jun; 18(6):2161-2173. PubMed ID: 32515968 [TBL] [Abstract][Full Text] [Related]
36. Folate-containing reduction-sensitive lipid-polymer hybrid nanoparticles for targeted delivery of doxorubicin. Wu B; Yu P; Cui C; Wu M; Zhang Y; Liu L; Wang CX; Zhuo RX; Huang SW Biomater Sci; 2015 Apr; 3(4):655-64. PubMed ID: 26222425 [TBL] [Abstract][Full Text] [Related]
37. Shell effects on acoustic performance of a drug-delivery system activated by ultrasound. Jablonowski LJ; Cochran MC; Eisenbrey JR; Teraphongphom NT; Wheatley MA J Biomed Mater Res A; 2017 Nov; 105(11):3189-3196. PubMed ID: 28771937 [TBL] [Abstract][Full Text] [Related]
39. Magnetic Targeting and Ultrasound Activation of Liposome-Microbubble Conjugate for Enhanced Delivery of Anticancer Therapies. Dwivedi P; Kiran S; Han S; Dwivedi M; Khatik R; Fan R; Mangrio FA; Du K; Zhu Z; Yang C; Huang F; Ejaz A; Han R; Si T; Xu RX ACS Appl Mater Interfaces; 2020 May; 12(21):23737-23751. PubMed ID: 32374147 [TBL] [Abstract][Full Text] [Related]
40. PLGA based particles as "drug reservoir" for antitumor drug delivery: characterization and cytotoxicity studies. Chronopoulou L; Domenici F; Giantulli S; Brasili F; D'Errico C; Tsaouli G; Tortorella E; Bordi F; Morrone S; Palocci C; Silvestri I Colloids Surf B Biointerfaces; 2019 Aug; 180():495-502. PubMed ID: 31103709 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]